31
Participants
Start Date
December 13, 2018
Primary Completion Date
July 20, 2020
Study Completion Date
July 20, 2020
VIB7734
Participants will receive VIB7734 via injection.
Placebo
Participants will receive placebo matching to VIB7734 via injection.
Viela Bio Investigative Site, Great Neck
Viela Bio Investigative Site, Duncansville
Viela Bio Investigative Site, Philadelphia
Viela Bio Investigative Site, Durham
Viela Bio Investigative Site, Charlotte
Viela Bio Investigative Site, Lawrenceville
Viela Bio Investigative Site, Jacksonville
Viela Bio Investigative Site, Miami Lakes
Viela Bio Investigative Site, Hialeah
Viela Bio Investigative Site, Fort Lauderdale
Viela Bio Investigative Site, St. Petersburg
Viela Bio Investigative Site, Birmingham
Viela Bio Investigative Site, Anniston
Viela Bio Investigative Site, Memphis
Viela Bio Investigative Site, Allen
Viela Bio Investigative Site, Mesquite
Viela Bio Investigative Site, Los Angeles
Viela Bio Investigative Site, Upland
Viela Bio Investigative Site, Danbury
Viela Bio Investigative Site, Bialystok
Viela Bio Investigative Site, Bydgoszcz
Viela Bio Investigative Site, Krakow
Viela Bio Investigative Site, Poznan
Viela Bio Investigative Site, Rzeszów
Viela Bio Investigative Site, Warsaw
Viela Bio Investigative Site, Wroclaw
Viela Bio Investigative Site, Barcelona
Viela Bio Investigative Site, Bilbao
Viela Bio Investigative Site, Madrid
Viela Bio Investigative Site, Seville
Lead Sponsor
Amgen
INDUSTRY